Company Profile | May 22, 2013

Pharmaceutical Services & Active Ingredients (PSAI) & Global Generics and Proprietary Products

Source: Dr. Reddy's

Through our three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including APIs, Custom Pharmaceutical Services, Generics, Biosimilars, Differentiated Formulations and New Chemical Entities (NCEs). Our therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics.

Custom Pharmaceutical Services (CPS)

Our Custom Pharmaceutical Services (CPS) business serves several ‘innovators’, both Big Pharma and emerging biotech, and a large number of emerging Pharma companies. Within a short span, we have become the largest CPS player from India and a partner-of-choice to innovators, offering top-end technical expertise, tailor-made pharma solutions and a track record of bringing innovations to the market quickly, efficiently and economically.

We offer both speed and flexibility. We have the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. Our end-to-end services and competitive pricing makes a compelling value proposition to our global ‘innovator’ customers.

Our niche technology-led acquisitions have made us a one-stop shop for many customers, which include:

  • High Containment & Cytotoxic Capabilities
  • Chiral Products and Technologies-ChiroTech
  • Steroids
  • PEGylation-PEGtech
  • Dosage

Product Services:

  • PIs to support combination development and differentiated formulation development of innovators
    • USDMFs
    • CEPs/EDMFs/JDMFs
  • Ready to use library of OTC, differentiated and combination formulations to support lifecycle management
    • ANDAs
    • Dossiers/European Dossiers

As one of India’s leading pharmaceutical companies, our activities cover the entire value chain of the pharmaceutical industry. We have a track record of new markets, novel partnerships, strategic acquisitions, deep customer-centricity, and a sustained focus on building our distinctive capabilities.

Through our commitment to affordable and innovative medicine, we touch people’s lives all around the world.